Does a Risk Management Plan Increase Safety Monitoring for the Use of Tumor Necrosis Factor-alpha Inhibitors?

被引：0
|
作者：
Chan, Meng-Ju [1 ]
Hsu, Chien-Ning [1 ,2 ]
Wen, Yen-Hsia [1 ]
Wang, Yu-Chin Lily [2 ]
机构：
[1] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
7
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [1] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [2] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors
    Yokota, Masaki
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E217 - E219
  • [3] Bradypnea in a child taking tumor necrosis factor-alpha inhibitors
    Sener, Seher
    Basaran, Ozge
    Bilginer, Yelda
    Kiper, Nural
    Ozen, Seza
    [J]. PEDIATRIC PULMONOLOGY, 2022, 57 (09) : 2267 - 2268
  • [4] Biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-alpha
    Chambers, RJ
    Marfat, A
    Cheng, JB
    Cohan, VL
    Damon, DB
    Duplantier, AJ
    Hibbs, TA
    Jenkinson, TH
    Johnson, KL
    Kraus, KG
    Pettipher, ER
    Salter, ED
    Shirley, JT
    Umland, JP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (06) : 739 - 744
  • [5] Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review
    Nair, Shaalina
    Kahlon, Simranjit Singh
    Sikandar, Rabia
    Peddemul, Aishwarya
    Tejovath, Sreedevi
    Hassan, Danial
    Patel, Khushbu K.
    Mostafa, Jihan A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [6] Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Ted R. Mikuls
    Arthur L. Weaver
    [J]. Current Rheumatology Reports, 2003, 5 (4) : 270 - 277
  • [7] Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis A meta-analysis
    Ma, Zeren
    Liu, Xiaoping
    Xu, Xiaosheng
    Jiang, Jie
    Zhou, Jian
    Wang, Jia
    Chen, Dewang
    Luo, Song
    [J]. MEDICINE, 2017, 96 (25)
  • [8] Tumor necrosis factor-alpha inhibitors and acne fulminans: Friend or foe?
    Barry, Kelly K.
    Neale, Holly D.
    Hawryluk, Elena B.
    [J]. PEDIATRIC DERMATOLOGY, 2023, 40 (04) : 678 - 680
  • [9] Tumor necrosis factor-alpha and tumor necrosis factor beta polymorphisms and risk of breast cancer: Review
    Aznag, Fatima Zahra
    El Kadmiri, Nadia
    Izaabel, El Hassan
    [J]. GENE REPORTS, 2018, 12 : 317 - 323
  • [10] Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients With Inflammatory Bowel Disease
    Gregory, Martin H.
    Spec, Andrej
    Stwalley, Dustin
    Gremida, Anas
    Mejia-Chew, Carlos
    Nickel, Katelin B.
    Ciorba, Matthew A.
    Rood, Richard P.
    Olsen, Margaret A.
    Deepak, Parakkal
    [J]. CROHNS & COLITIS 360, 2023, 5 (02)
12345